AstraZeneca may have washed its hands of AZD4041 after the opioid use disorder (OUD) prospect demonstrated a potential drug-drug interaction last year, but the pharma’s development partner, Eolas T | ...

WPP shares rallied following yesterday’s slump, putting on 7.8p to 436.4p after announcing Microsoft executive Cindy Rose as ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for adeno-associated virus (AAV) capsids from existing ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

Boston Consulting Group CEO apologizes for Israeli-backed Gaza aid project Top consulting firm fires two partners over involvement in aid initiative beset by violence and controversy.